Precision System Science Co Aandeel

Precision System Science Co EPS

De Winst per Aandeel (EPS) van Precision System Science Co (7707.T) per 20 aug 2026 bedraagt -9,21 JPY. In het voorgaande jaar bedroeg Winst per Aandeel (EPS) -40,59 JPY — een verandering van -77,32% (hoger).

EPS

-9,21JPY

YoY

-77,32%

Laatst bijgewerkt:

Winst per Aandeel (EPS) van Precision System Science Co is 2026 -9,21 JPY. Winst per Aandeel (EPS) van Precision System Science Co was 2025 -40,59 JPY. Het is daarmee -77,32% hoger lager dan het jaar ervoor.
Access this data via the Eulerpool API

Precision System Science Co Aandelenanalyse

Wat doet Precision System Science Co? Precision System Science Co Ltd is a leading company in the field of medical research and diagnostics, founded in Japan in 1989. The company is headquartered in Chiba, Japan and operates branches in Europe, the USA, and Asia. Its business model is focused on providing a wide range of instruments, devices, and services for research, diagnostics, and therapy in the medical industry. The company designs and produces its own products and also offers customized solutions for customers. It is divided into different divisions, including instruments and devices for molecular biology and diagnostics, cell analysis, microscopy, and sample processing. They offer products such as PCR systems, qPCR systems, automated sample preparation systems, and RNA isolation kits for molecular biology and diagnostics. They also produce cell counting systems, flow cytometers, high-speed imaging systems, multi-well plate readers for cell analysis. In the microscopy division, the company manufactures high-quality fluorescence microscopes and deconvolution microscopes for protein and DNA molecule analysis, disease diagnostics, drug development, etc. In the sample processing division, they produce automated stations used for preparing samples for genomics and proteomics analysis. The company is also engaged in research and development of medical devices and instruments to improve the quality of medical diagnostics and therapy. A successful product example is the qPCR thermocycler MIQE used in the diagnosis and therapy of diseases like cancer. Precision System Science Co Ltd has played a significant role in fighting the COVID-19 pandemic by producing test kits for diagnosis and offering advanced PCR systems for mass testing. They are committed to continuous innovation and improvement of their products and services to meet the changing needs of the medical industry. With their strong presence and dedication to providing state-of-the-art and innovative products and services, they will remain a major player in the global market for medical devices and instruments. Precision System Science Co is een van de meest populaire bedrijven op Eulerpool.

Veelgestelde vragen over het aandeel Precision System Science Co

Winst per Aandeel (EPS) van Precision System Science Co bedraagt -9,21 JPY in 2026.

Winst per Aandeel (EPS) van Precision System Science Co is veranderd van -40,59 JPY naar -9,21 JPY, wat een verandering van -77,32% vertegenwoordigt. De waarde is hoger dan het vorige jaar.

Op Eulerpool vindt u de volledige historische ontwikkeling van Winst per Aandeel (EPS) Precision System Science Co sinds 2006 – met jaarlijkse waarden, grafieken en gedetailleerde analyse.

De winst per aandeel meet het deel van de bedrijfswinst dat aan elk uitstaand aandeel is toegewezen. Het is een sleutelmaatstaf voor het beoordelen van de winstgevendheid op aandeelbasis.

WPA = Nettowinst / Uitstaande aandelen

Access this data via the Eulerpool API

Winst-en-verliesrekening — Precision System Science Co

Alle kengetallen — Precision System Science Co